{"id":"CHEMBL1084546","canonicalSmiles":"CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O","inchiKey":"MZDKLVOWGIOKTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00562271","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 562271","PF-562271","Pf-00562271"],"crossReferences":{"PubChem":["103905684"]},"childChemblIds":["CHEMBL2430359"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1092830","canonicalSmiles":"Cc1cc(NC(=O)/N=c2/[nH]cc(CCNc3cc(Nc4nc[nH]n4)ncn3)s2)c(C(F)(F)F)o1","inchiKey":"KNTGXMNWVXZIMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1092830","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11662","canonicalSmiles":"O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1","inchiKey":"SHZKQBHERIJWAO-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZAGREL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KCT-0809","Ozagrel","Ozagrel sodium"],"crossReferences":{"Wikipedia":["Ozagrel"],"drugbank":["DB12017"]},"childChemblIds":["CHEMBL1715705","CHEMBL542549"],"linkedTargets":{"rows":["ENSG00000059377"],"count":1},"linkedDiseases":{"rows":["EFO_1000906","MONDO_0002679"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1184360","canonicalSmiles":"CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1","inchiKey":"WGMYEOIMVYADRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMTHAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1972},"tradeNames":[],"synonyms":["Diamthazole","Dimazole"],"crossReferences":{"PubChem":["144205400","29216167"],"drugbank":["DB13858"]},"childChemblIds":["CHEMBL346235","CHEMBL1509531"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  United States initially in 1972 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL1200334","canonicalSmiles":"CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2.Cl","inchiKey":"GAQAKFHSULJNAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORICIZINE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1075","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethmozine"],"synonyms":["Moracizine hydrochloride","Moricizine hcl","Moricizine hydrochloride"],"crossReferences":{"PubChem":["144204173","170465141","24840971","856698"],"chEBI":["60937"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200510","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"YAVZHCFFUATPRK-YZPBMOCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN STEARATE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bristamycin","Erypar","Erythrocin","Erythrocin 500","Erythrocin acne pack","Erythrocin stearate","Erythromycin stearate","Ethril 250","Ethril 500","Pfizer-e","Wyamycin s"],"synonyms":["Abboticine","Erythromycin stearate","Erythromycini stearas","NSC-756747","Sk-erythromycin"],"crossReferences":{"DailyMed":["erythromycin%20stearate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964."}
{"id":"CHEMBL1200664","canonicalSmiles":"CC(O)C(=O)[O-].[K+]","inchiKey":"PHZLMBHDXVLRIX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM LACTATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-326","E326","INS NO.326","INS-326","Lactic acid, monopotassium salt","Lactic acid, potassium salt","Monopotassium lactate","Potassium 2-hydroxypropanoate","Potassium lactate","Potassium lactate (solution)"],"crossReferences":{"DrugCentral":["4695"],"Wikipedia":["Potassium_lactate"],"drugbank":["DB09483"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1200837","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1.Cl","inchiKey":"CHDPSNLJFOQTRK-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBETAXOLOL HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201274","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxon"],"synonyms":["AL-1577A","AL1577A","Levobetaxolol hcl","Levobetaxolol hydrochloride"],"crossReferences":{"chEBI":["59256"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 2 investigational indications."}
{"id":"CHEMBL1201573","drugType":"Protein","blackBoxWarning":true,"name":"OPRELVEKIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neumega"],"synonyms":["Interleukin-11 (2-178)","Oprelvekin"],"crossReferences":{"DrugCentral":["5026"],"Wikipedia":["Oprelvekin"]},"linkedTargets":{"rows":["ENSG00000137070"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","Orphanet_903","EFO_0000339","MONDO_0019465","EFO_0000095","EFO_0000191","MONDO_0018906","Orphanet_98878","EFO_1000550","HP_0001873"],"count":10},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for thrombocytopenia and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201618","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glucagen","Glucagon"],"synonyms":["Glucagon chloride","Glucagon hcl","Glucagon hydrochloride","Glucagon, monohydrochloride"],"crossReferences":{"DailyMed":["glucagon%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","HP_0001943","EFO_0000400","MONDO_0005148","EFO_0001073"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 3 investigational indications."}
{"id":"CHEMBL1201743","canonicalSmiles":"Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2","inchiKey":"TUAZNHHHYVBVBR-NHKADLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAXAGLIPTIN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL385517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Onglyza"],"synonyms":["Saxagliptin HCl","Saxagliptin hcl","Saxagliptin hydrochloride"],"crossReferences":{"DailyMed":["saxagliptin%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for type 2 diabetes mellitus."}
{"id":"CHEMBL1208422","canonicalSmiles":"O=C(O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(=O)c(I)c-2oc2c(I)c(O)c(I)cc12","inchiKey":"VDNLFJGJEQUWRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSE BENGAL","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-10463","Rose bengal"],"crossReferences":{"PubChem":["29215482","29215483"],"drugbank":["DB11182"],"chEBI":["87202"]},"childChemblIds":["CHEMBL594741","CHEMBL2359093","CHEMBL3989461","CHEMBL3989792"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 6 investigational indications."}
{"id":"CHEMBL1214185","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"RXZBMPWDPOLZGW-XMRMVWPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXITHROMYCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rulid","Rulide"],"synonyms":["NSC-758443","RU 28965","RU 965","RU-28965","RU-965","Roxithromycin"],"crossReferences":{"Wikipedia":["Roxithromycin"],"chEBI":["48935"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1235338","canonicalSmiles":"CCCCCCCCCCCCCCCC=O","inchiKey":"NIOYUNMRJMEDGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALMITALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Palmitaldehyde"],"crossReferences":{"drugbank":["DB03381"],"chEBI":["17600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL124363","canonicalSmiles":"C#C[C@@]1(CO)C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1","inchiKey":"OSYWBJSVKUFFSU-SKDRFNHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENSAVUDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4'-Ethynyl Stavudine","4'-ed4t","4'-ethynylstavudine","BMS-986001","Censavudine","Censavudine, 4'-ethynyl-d4t","Festinavir","OBP-601"],"crossReferences":{"Wikipedia":["Festinavir"],"drugbank":["DB12074"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL129795","canonicalSmiles":"O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O","inchiKey":"DXDRHHKMWQZJHT-FPYGCLRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOLIQUIRITIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoliquiritigenin"],"crossReferences":{"PubChem":["14728533","26747225","26752559","50105356","50105357","50105358","50105359","50105360","90340639","93576722"],"Wikipedia":["Isoliquiritigenin"],"drugbank":["DB03285"],"chEBI":["310312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1313657","canonicalSmiles":"N=C(N)NN=Cc1c(Cl)cccc1Cl","inchiKey":"WDZVGELJXXEGPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1313657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204483","170465364","26665151"],"drugbank":["DB00629"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL132186","canonicalSmiles":"CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"HOVAGTYPODGVJG-XUUWZHRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL132186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01642"],"chEBI":["320055"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330729","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1.Cl","inchiKey":"OPXKTCUYRHXSBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLENBUTEROL HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL49080","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clenbuterol hcl","Clenbuterol hydrochloride","NAB 365 CL","NAB-365","NAB-365CL","Ventipulmin"],"crossReferences":{"PubChem":["11533014","26749999","56422505"],"chEBI":["31410"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1395","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"GCKMFJBGXUYNAG-HLXURNFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTESTOSTERONE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Android 10","Android 25","Android 5","Metandren","Methitest","Methyltestosterone","Oreton","Oreton methyl","Perandren","Plex hormone","Potensan fte","Testovis","Testred","Virilon"],"synonyms":["17-methyltestosterone","CDB-110","L 589.372","L-589.372","L-589372","Methyltestosterone","Methyltestosterone ciii","NSC-139965","NSC-9701","Oxandrolone impurity, methyltestosterone-","RU 24400","RU-24400","U-2842"],"crossReferences":{"DailyMed":["methyltestosterone"],"PubChem":["144206712","144206713","144214019","170464631","17388912","26719668","56463771"],"TG-GATEs":["41"],"Wikipedia":["Methyltestosterone"],"drugbank":["DB06710"],"chEBI":["27436"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_1001078","MONDO_0002146","MONDO_0007254","EFO_0003922"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1538","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C","inchiKey":"JFVZFKDSXNQEJW-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR DISOPROXIL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viread"],"synonyms":["(r)-bis(poc)pmpa","Bis-poc-pmpa","GS-4331","Tenofovir bis(isopropyloxycarbonyloxymethyl) ester","Tenofovir disoproxil"],"crossReferences":{"DailyMed":["tenofovir%20disoproxil%20fumarate"],"drugbank":["DB00300"],"chEBI":["63717"]},"childChemblIds":["CHEMBL4594453","CHEMBL1486","CHEMBL3185360"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 7 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1668019","canonicalSmiles":"CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl","inchiKey":"QNNBMSGFNQRUEH-PQQSRXGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APLAVIROC HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1255794","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aplaviroc hcl","Aplaviroc hydrochloride","GW-873140A","GW873140A"],"crossReferences":{"PubChem":["144210531"]},"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1697856","canonicalSmiles":"CCOc1ccc(NC(=O)CC(C)O)cc1","inchiKey":"LIAWQASKBFCRNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCETIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Nephrotoxicity"],"year":1986},"tradeNames":[],"synonyms":["3-hydroxy-4-butyrophenetidide","3-hydroxy-p-butyrophenetidide","Betadid","Bucetin","NSC-320045","NSC-759243"],"crossReferences":{"PubChem":["144205887","144209014","144213206","170465885"],"TG-GATEs":["139"],"drugbank":["DB13278"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain. It was withdrawn in Germany  in 1986 due to Nephrotoxicity."}
{"id":"CHEMBL1743036","drugType":"Antibody","blackBoxWarning":false,"name":"LEXATUMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ETR2-ST01","HGS-1018","HGS-ETR2","HGS1018","Lexatumumab"],"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_0000637","EFO_0000174","EFO_0002918","EFO_0000621"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL177101","canonicalSmiles":"O=S(=O)(NCCC(F)(F)F)c1ccc2c(c1)CN[C@@H](CF)C2","inchiKey":"BBUDQLKRZPRPFD-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL177101","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1779325","canonicalSmiles":"CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)O)C(N)=O","inchiKey":"BSOQXXWZTUDTEL-QAQREVAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MURAMYL DIPEPTIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muramyl dipeptide","N-acetylmuramyl dipeptide"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1788390","canonicalSmiles":"CCOC(=O)/C(=C/c1ncc([N+](=O)[O-])n1C)C(C)=O","inchiKey":"GCHKUUOPYMFGEY-VMPITWQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPENIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Propenidazole"],"crossReferences":{"drugbank":["DB13319"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1814493","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN)C(=O)O","inchiKey":"MVORZMQFXBLMHM-QWRGUYRKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL1814493","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11296"],"chEBI":["75430"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1884833","canonicalSmiles":"C[N+]1(CCC(C(N)=O)(c2ccccc2)c2ccccc2)CCCCC1","inchiKey":"QDIYJDPBMZUZEH-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPIVERINIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenpiverinium","Fenpiverinium cation","Fenpiverinium ion"],"crossReferences":{"PubChem":["26758043"],"drugbank":["DB13759"]},"childChemblIds":["CHEMBL2106138"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1901349","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)[O-].CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)[O-].[Ca+2]","inchiKey":"FAPWYRCQGJNNSJ-UBKPKTQASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM PANTOTHENATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1594","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Calpan","Pantholin"],"synonyms":["Calcium Pantothenate","Calcium pantotenate","Calcium pantothenate","Calcium pantothenate, d-","D-ca pantothenate","D-calcium pantothenate","NSC-36292","Pantothenic acid (as calcium)","Pantothenic acid calcium salt","Vitamin b5, calcium salt"],"crossReferences":{"PubChem":["144206987","57261285"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL19344","canonicalSmiles":"Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1","inchiKey":"WZRCQWQRFZITDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HIGENAMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dl-demethylcoclaurine","Higenamine"],"crossReferences":{"Wikipedia":["Higenamine"],"drugbank":["DB12779"],"chEBI":["18418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197194","canonicalSmiles":"COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1","inchiKey":"XPRDUGXOWVXZLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIDOFLUDIMUS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4SC-101","IMU-838","Imu-838","NSC-717824","SC-12267","SC12267","Vidofludimus"],"crossReferences":{"PubChem":["174007069"],"drugbank":["DB15446"]},"linkedTargets":{"rows":["ENSG00000102967"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0004268","MONDO_0100096","MONDO_0005301","EFO_0003929","EFO_0003767"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2063090","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1","inchiKey":"OBMNJSNZOWALQB-NCQNOWPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAZOPREVIR","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Grazoprevir","Grazoprevir hydrate","Grazoprevir monohydrate","MK-5172","MK-5172 ANHYDROUS","MK-5172 MONOHYDRATE"],"crossReferences":{"DailyMed":["grazoprevir"],"drugbank":["DB11575"]},"childChemblIds":["CHEMBL3039533","CHEMBL2063078"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for chronic hepatitis c virus infection and viral disease and has 1 investigational indication."}
{"id":"CHEMBL2074765","canonicalSmiles":"CCCCCCCCC/C=C/C=C/C(=O)NCC(=O)N[C@@H]1C(O)[C@H](O)C(Nc2ncnc3[nH]cnc23)OC1[C@H](O)CO","inchiKey":"LQIPDFIUPOYMPR-RMOMFDTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KRN5500","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRN5500","Krn-5500","Krn5500","NSC-650426","SPK-241"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103854","canonicalSmiles":"CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"SETFNHZTVGTBHC-XGLFQKEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMADACYCLINE TOSYLATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1689772","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nuzyra"],"synonyms":["Omadacycline tosilate","Omadacycline tosylate","PTK 0796","PTK-0796"],"crossReferences":{"DailyMed":["omadacycline%20tosylate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for skin disease and bacterial pneumonia and has 2 investigational indications."}
{"id":"CHEMBL2104238","canonicalSmiles":"CCCCNCC(=O)Nc1c(C)cccc1Cl","inchiKey":"VWYQKFLLGRBICZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTANILICAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butacetoluide","Butanilicaine"],"crossReferences":{"drugbank":["DB13328"],"chEBI":["55518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105637","canonicalSmiles":"Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F","inchiKey":"DYDCPNMLZGFQTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DELAFLOXACIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABT-492","Delafloxacin","RX-3341","WQ-3034"],"crossReferences":{"DailyMed":["delafloxacin%20meglumine"],"drugbank":["DB11943"]},"childChemblIds":["CHEMBL2105638"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for skin disease and bacterial disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106467","canonicalSmiles":"Cc1ccc(C(C)C)c(OCC2=NCCN2)c1","inchiKey":"QRORCRWSRPKEHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYMAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tymazoline"],"crossReferences":{"drugbank":["DB08803"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107175","canonicalSmiles":"N#Cc1c(N(CC(=O)O)CC(=O)O)sc(C(=O)O)c1CC(=O)O","inchiKey":"DJSXNILVACEBLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANELIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ranelic acid"],"childChemblIds":["CHEMBL3707306","CHEMBL3182450"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL2108034","drugType":"Protein","blackBoxWarning":false,"name":"IBOCTADEKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iboctadekin","Ifn-gamma-inducing factor","Il-1 gamma","Il-18","Interferon gamma-inducing factor","Interleukin-1 gamma","Interleukin-18","SB-485232"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108135","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYGELINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gelatin solution, special intravenous","Polygeline"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108184","drugType":"Small molecule","blackBoxWarning":false,"name":"CROFELEMER","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fulyzaq","Mytesi","Provir","Virend"],"synonyms":["Crofelemer","NP-303","SP-303","TRN-002"],"crossReferences":{"DailyMed":["crofelemer"],"DrugCentral":["4744"]},"linkedTargets":{"rows":["ENSG00000001626","ENSG00000131620"],"count":2},"linkedDiseases":{"rows":["EFO_0000765","HP_0002014","EFO_0000555","HP_0002028","MONDO_0007254","HP_0004798"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for aids and diarrhea and has 2 investigational indications."}
{"id":"CHEMBL2108243","drugType":"Small molecule","blackBoxWarning":false,"name":"CORN OIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Corn oil","Corn oil, unhydrogenated","Maydol","Oleum maydis","Vegetable oil, corn","Zea mays oil"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2108612","drugType":"Antibody","blackBoxWarning":false,"name":"IRATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iratumumab","MDX-060"],"linkedTargets":{"rows":["ENSG00000120949"],"count":1},"linkedDiseases":{"rows":["EFO_0001642","EFO_0000574","EFO_0000183"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108651","drugType":"Protein","blackBoxWarning":false,"name":"TALACTOFERRIN ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LF-00","LF00","Talactoferrin","Talactoferrin alfa","Talactoferrinum alfa"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108664","drugType":"Protein","blackBoxWarning":false,"name":"VERPASEP CALTESPEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCG-65-E7","BCG65-E7","HSPE-7","HSPE7","Verpasep caltespen"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109220","drugType":"Unknown","blackBoxWarning":false,"name":"PERTUSSIS VACCINE ADSORBED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pertussis vaccine adsorbed"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109271","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-210","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["520C9XH22","MDX-210"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109468","drugType":"Antibody","blackBoxWarning":false,"name":"HUMAX-IL15","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMAX-IL15"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110641","canonicalSmiles":"N=C(N)NNCCOc1c(Cl)cccc1Cl","inchiKey":"XIHXRRMCNSMUET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOCLOR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanochlor","Guanoclor","NSC-108163"],"crossReferences":{"drugbank":["DB13779"]},"childChemblIds":["CHEMBL3989456"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111016","canonicalSmiles":"CC[N+](C)(CC)CCSC1=Nc2ccccc2N=C(c2ccc(Sc3ccccc3)cc2)C1","inchiKey":"MAJFXTGRPADJLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIBEZONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tibezonium cation","Tibezonium ion"],"childChemblIds":["CHEMBL2107065"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2178579","canonicalSmiles":"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl","inchiKey":"YQYFEGTYCUQBEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELUBRIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elubrixin","SB-656933","SB-656933-AAF","SB656933","Sb-656933"],"crossReferences":{"drugbank":["DB12135"]},"childChemblIds":["CHEMBL3039524"],"linkedTargets":{"rows":["ENSG00000180871"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","Orphanet_586","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL221186","canonicalSmiles":"CN(C)CCNC(=O)COc1c2cccc1Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)C2","inchiKey":"CQVAQQNDZCZBSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTX-008","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CALIXARENE 0118","KM-0118","OTX008","Otx-008","Otx008","PTX-008"],"crossReferences":{"drugbank":["DB13123"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2219422","canonicalSmiles":"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl","inchiKey":"AFJRDFWMXUECEW-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFURESERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASB-183","ASB183","Afuresertib","GSK-2110183","GSK-2110183C","GSK2110183","GSK2110183C","Gsk-2110183"],"crossReferences":{"drugbank":["DB11648"]},"childChemblIds":["CHEMBL2219423"],"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000318","MONDO_0008170","MONDO_0007254","EFO_0001378","MONDO_0008315","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2219773","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CUSTIRSEN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Custirsen sodium","ISIS 112989","ISIS-112989","OGX-011","Ogx 011"],"linkedTargets":{"rows":["ENSG00000120885"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","MONDO_0008315","EFO_0003060"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL223228","canonicalSmiles":"O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1","inchiKey":"XPOQHMRABVBWPR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFAVIRENZ","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efavirenz","Sustiva","Sustiva 600"],"synonyms":["Efavirenz","Efavirenz teva","Efavirenzum","NSC-742403","Stocrin","Sustiva","Viraday"],"crossReferences":{"DailyMed":["efavirenz"],"PubChem":["144205135","170464810","26719858","49681705"],"Wikipedia":["Efavirenz"],"drugbank":["DB00625"],"chEBI":["119486"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL239243","canonicalSmiles":"NCCS(=O)(=O)O","inchiKey":"XOAAWQZATWQOTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAURINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["O-due"],"synonyms":["Aminoethylsulfonic acid","Ethanesulfonic acid, 2-amino-","FEMA NO. 3813","NSC-32428","Taurate","Taurine"],"crossReferences":{"PubChem":["11111855","11113407","124881546","144203828","144209718","170465726","17389723","26751645","46500351","50104337","90924"],"Wikipedia":["Taurine"],"drugbank":["DB01956"],"chEBI":["15891"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2431768","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1","inchiKey":"UFPFGVNKHCLJJO-SSKFGXFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LCL-161","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LCL161","Lcl 161","Lcl-161","Lcl161","Nvp-lcl 161"],"crossReferences":{"drugbank":["DB12085"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL25719","canonicalSmiles":"CC(C)=CCC/C(C)=C/CO","inchiKey":"GLZPCOQZEFWAFX-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GERANIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Geraniol"],"crossReferences":{"PubChem":["144203561","144209584","144210456","170465692","26748503","26753731","4252542","74795"],"Wikipedia":["Geraniol"],"drugbank":["DB14183"],"chEBI":["17447"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269881","canonicalSmiles":"Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1","inchiKey":"MWGXGTJJAOZBNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-2058","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-2058"],"crossReferences":{"PubChem":["582481","49674686"],"drugbank":["DB02407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277041","canonicalSmiles":"CSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"WUUGFSXJNOTRMR-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTHIOADENOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Methyl-Thioadenosine","Methylthioadenosine"],"crossReferences":{"drugbank":["DB02282"],"chEBI":["17509"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282614","canonicalSmiles":"c1cc2c(c(N3CCNCC3)c1)OCCO2","inchiKey":"WVLHGCRWEHCIOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELTOPRAZINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU-28853","Eltoprazine"],"crossReferences":{"Wikipedia":["Eltoprazine"],"drugbank":["DB12883"]},"childChemblIds":["CHEMBL3187065"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL303004","canonicalSmiles":"NCCCCCCN","inchiKey":"NAQMVNRVTILPCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Hexane-1,6-Diamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexane-1,6-Diamine"],"crossReferences":{"PubChem":["144209286","144213440","17389453"],"Wikipedia":["Hexamethylenediamine"],"drugbank":["DB03260"],"chEBI":["39618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137318","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1","inchiKey":"QUQKKHBYEFLEHK-QNBGGDODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAZOPARIB TOSYLATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3137320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talzenna"],"synonyms":["BMN 673ts","BMN-673TS","Talazoparib tosylate"],"crossReferences":{"DailyMed":["talazoparib%20tosylate"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0005537","MONDO_0007254","EFO_0000222","EFO_0000305","EFO_0003060"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3235620","canonicalSmiles":"COC1=C(OC)[C@H](O)[C@H](C/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)[C@@H](C)C1=O","inchiKey":"LJTSIMVOOOLKOL-FNRDIUJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTROQUINONOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antroquinonol","Antroquinonol a","Hocena","J3.387.174K"],"crossReferences":{"drugbank":["DB12326"],"chEBI":["65415"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL32800","canonicalSmiles":"CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1","inchiKey":"LSLYOANBFKQKPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["New Zealand"],"classes":["Respiratory toxicity"],"year":1990},"tradeNames":["Berodual","Berodual n","Berotec","Berotec 100","Berotec 200","Berotec [as hydrobromide]","Duovent"],"synonyms":["Airum","Dosberotec","Fenoterol","Fenoterol hbr","Fenoterol hydrobromide","NSC-757811","Partusisten","TH 1165A","TH 1165A FREE BASE","TH 1165A [AS HYDROBROMIDE SALT]","TH-1165","TH-1165A","TH-1165A FREE BASE"],"crossReferences":{"PubChem":["90340690"],"Wikipedia":["Fenoterol"],"drugbank":["DB01288"],"chEBI":["149226"]},"childChemblIds":["CHEMBL537445"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","MONDO_0004979","EFO_0000373","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for airway obstruction and has 3 investigational indications. It was withdrawn in New Zealand  in 1990 due to Respiratory toxicity."}
{"id":"CHEMBL328944","canonicalSmiles":"O=C(CP(=O)(O)O)NO","inchiKey":"LDKRAXXVBWHMRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHONOACETOHYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxycarbamoylmethyl-Phosphonic Acid"],"crossReferences":{"drugbank":["DB03645"],"chEBI":["44692"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3317781","canonicalSmiles":"N[C@H](C(=O)O)[C@@H](O)C(=O)O","inchiKey":"YYLQUHNPNCGKJQ-NHYDCYSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3317781","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03640"],"chEBI":["17576"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL340211","canonicalSmiles":"O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1","inchiKey":"XTKDAFGWCDAMPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZAPERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stresnil","Suicalm"],"synonyms":["Azaperone","Azaperone for veterinary use","NSC-170976","R 1929","R-1929"],"crossReferences":{"PubChem":["11112496","124882409","144204063","170465697","26749048","56463640"],"Wikipedia":["Azaperone"],"drugbank":["DB11376"],"chEBI":["88301"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL346919","canonicalSmiles":"COc1cc(C(C)=O)ccc1O","inchiKey":"DFYRUELUNQRZTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APOCYNIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-hydroxy-3-methoxyacetophenone","Acetovanillone","Apocynin","NSC-209524"],"crossReferences":{"PubChem":["51088030"],"Wikipedia":["Apocynin"],"drugbank":["DB12618"],"chEBI":["2781"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545043","canonicalSmiles":"CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(-c4ncco4)c(OCC(=O)O)c3)CC2)cc1","inchiKey":"ZMZNWNTZRWXTJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASAPIPRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asapiprant","S-555739"],"linkedTargets":{"rows":["ENSG00000168229"],"count":1},"linkedDiseases":{"rows":["EFO_0003956"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545203","drugType":"Small molecule","blackBoxWarning":false,"name":"RG7342","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO6806127","Rg7342"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545402","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-820","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xl-820"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404"],"count":6},"linkedDiseases":{"rows":["Orphanet_44890","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL364869","canonicalSmiles":"NS(=O)(=O)c1ccc2c(c1)CCC2","inchiKey":"XVQJTFMKKZBBSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Indan-5-Sulfonic Acid Amide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indan-5-Sulfonic Acid Amide"],"crossReferences":{"drugbank":["DB08165"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL365776","canonicalSmiles":"O=C(Nc1ccc2[nH]cc(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1","inchiKey":"HIUFYIOMUILESI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL365776","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08091"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707235","canonicalSmiles":"N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O","inchiKey":"ZWPRRQZNBDYKLH-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMIGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gemigliptin","LC-15-0444","LC-150444","LC15-0444"],"crossReferences":{"drugbank":["DB12412"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","EFO_0000400","MONDO_0005148","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707366","canonicalSmiles":"C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)O","inchiKey":"HJCMDXDYPOUFDY-WHFBIAKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALANYL GLUTAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ala-gln","Alanyl glutamine","Alanyl-glutamine dipeptide","Dipeptamin","FEMA NO. 4712","Glutamax","L-alanyl-l-glutamine","L-alanyl-l-glutamine amino acid","Sustamine"],"crossReferences":{"drugbank":["DB11876"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL374713","canonicalSmiles":"OCc1n[nH]nc1-c1ccc2c(-c3cc4cc(CN5CCCCC5)ccc4[nH]3)n[nH]c2c1","inchiKey":"FNWHPLLNMLOZTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL374713","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07213"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833359","drugType":"Unknown","blackBoxWarning":false,"name":"COBAMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-deoxyadenosyl-b12","5'-deoxyadenosylcobalamin","Ademide","Adenosyl-b12","Adocbl","Calomide","Cobaltamin s","Cobamamide","Cobamamidum","Cobanzyme","Coenzile","Coenzyme b12","Dibencozide","Dibenzcozamide","Dimebenzcozamide","Enzicoba","HL-009","Heraclene","Indusil","LM 176","LM-176","NSC-757791","Vitamin b12 coenzyme"],"crossReferences":{"DrugCentral":["4404"]},"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL397420","canonicalSmiles":"CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O","inchiKey":"VABCILAOYCMVPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACENOCOUMAROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sinthrome"],"synonyms":["Acenocoumarin","Acenocoumarol","Mini-sintrom","NSC-760052","Nicoumalone"],"crossReferences":{"PubChem":["144203981","170465636"],"Wikipedia":["Acenocoumarol"],"drugbank":["DB01418"],"chEBI":["53766"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","HP_0001871","EFO_0003827","EFO_0000756","EFO_0004286","HP_0004419"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 3 investigational indications."}
{"id":"CHEMBL3989569","canonicalSmiles":"CCCCCN(C)CCC(O)(P(=O)([O-])O)P(=O)(O)O.O.[Na+]","inchiKey":"VBDRTGFACFYFCT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IBANDRONATE SODIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL997","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Boniva","Ibandronate sodium"],"synonyms":["BM 21.0955 NA H20","BM-21.0955","BM-210955","Ibandronate monosodium monohydrate","Ibandronate sodium","Ibandronate sodium hydrate","Ibandronate sodium monohydrate","Ibandronic acid sodium salt","Ibandronic acid sodium salt monohydrate","Ibandronic sodium monohydrate","NSC-759815"],"crossReferences":{"DailyMed":["ibandronate%20sodium"]},"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003854","MONDO_0007254","EFO_0003882","EFO_0003843","MONDO_0024880"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for osteoporosis and postmenopausal osteoporosis and has 3 investigational indications."}
{"id":"CHEMBL399910","canonicalSmiles":"O=C1C[C@@H](c2ccccc2)Oc2cc(O)cc(O)c21","inchiKey":"URFCJEUYXNAHFI-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINOCEMBRIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S)-Pinocembrin","Dihydrochrysin","Galangin flavanone","NSC-279005","NSC-43318","Pinocembrin"],"crossReferences":{"PubChem":["46501212"],"Wikipedia":["Pinocembrin"],"chEBI":["28157"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4065616","canonicalSmiles":"CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1","inchiKey":"RWWYLEGWBNMMLJ-YSOARWBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMDESIVIR","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Veklury"],"synonyms":["GS 5734","GS-5734","Gs-5734","Remdesivir"],"crossReferences":{"drugbank":["DB14761"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for severe acute respiratory syndrome and covid-19 and has 3 investigational indications."}
{"id":"CHEMBL421138","canonicalSmiles":"Cc1cc(C=O)c(OP(=O)(O)O)c(C=O)c1","inchiKey":"NAYNUXXSJZLKPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL421138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03828"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42208","canonicalSmiles":"CN(Cc1cn(C)c2ccccc12)C(=O)/C=C/c1cnc2c(c1)CCC(=O)N2","inchiKey":"VAZMNDXVXVUKFY-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL42208","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42336","canonicalSmiles":"CSCC[C@H](N)C(=O)O","inchiKey":"FFEARJCKVFRZRR-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIONINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["L-methionine","Methionine","NSC-22946","Racemethionine"],"crossReferences":{"Wikipedia":["Methionine"],"drugbank":["DB00134"],"chEBI":["16643"]},"childChemblIds":["CHEMBL1770614","CHEMBL2106977"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL4243974","canonicalSmiles":"CC1=C(CC(=O)NCc2ccccc2)c2cc(F)ccc2/C1=C\\c1ccncc1.Cl","inchiKey":"KGXPDNOBLLACKL-BWLGBDCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-461","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4068108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cp 461","Cp-461","OSI-461"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297624","canonicalSmiles":"CCOC(=O)C12CCC(NCC(=O)N3C[C@@H](F)C[C@H]3C#N)(CC1)CC2","inchiKey":"AKFNKZFJBFQFAA-DIOPXHOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISEGLIPTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisegliptin","KRP-104","Krp-104"],"crossReferences":{"drugbank":["DB06127"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297642","canonicalSmiles":"CC(=O)N(CCCCNCCCn1c(=O)[nH]c2ccccc2c1=O)CCCn1c(=O)[nH]c2ccccc2c1=O","inchiKey":"SJZBPVOSFYUHFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTAPLIMASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.046.690J","Otaplimastat","Sp-8203"],"crossReferences":{"drugbank":["DB11670"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297797","drugType":"Unknown","blackBoxWarning":false,"name":"NNC0114-0006","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NN-8828","NN-9828","Nnc0114-0006"],"linkedTargets":{"rows":["ENSG00000138684"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0000400"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297833","drugType":"Antibody","blackBoxWarning":false,"name":"MEZAGITAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mezagitamab","TAK-079","TAK079","Tak-079"],"linkedTargets":{"rows":["ENSG00000004468"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0007160","EFO_0002690","EFO_0001378","EFO_0005140","EFO_0004991"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297856","drugType":"Antibody","blackBoxWarning":false,"name":"ZIMBERELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-122","AB122","Ab-122","Ab122","GLS-010","Gls-010","WBP-3055","WBP3055","Zimberelimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000616","EFO_0002618","EFO_1001480","MONDO_0002974","EFO_0000756","EFO_0000673","EFO_1000657","EFO_0000519","EFO_0003060","MONDO_0008315"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298057","drugType":"Unknown","blackBoxWarning":false,"name":"NIS-793","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NIS-793","NIS793","Nis-793","Nis793"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL43708","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12.O","inchiKey":"GSOSVVULSKVSLQ-JJVRHELESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIPENEM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL148","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Imipemide","Imipenem","Imipenem hydrate","Imipenem monohydrate","Imipenem monohydrate (h2o)","MK-0787","NSC-759901"],"crossReferences":{"DailyMed":["imipenem"],"Wikipedia":["Imipenem"],"chEBI":["51799"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL448570","canonicalSmiles":"CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"VDTNNGKXZGSZIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBUTAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BZ 55","BZ-55","CA 1022","Carbutamide","Diaboral","Emedan","Glucidoral","Glucofren","Glybutamide","Invenol","NSC-242409","U-6987"],"crossReferences":{"PubChem":["144205226","170466249"],"Wikipedia":["Carbutamide"],"drugbank":["DB13406"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL449303","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C","inchiKey":"NODILNFGTFIURN-GZPRDHCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RB2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside Rb2"],"crossReferences":{"drugbank":["DB06748"],"chEBI":["77152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451332","canonicalSmiles":"NS(=O)(=O)c1ccc(CCC(=O)O)cc1","inchiKey":"JUEONDBIBADVGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-(4-Sulfamoylphenyl)Propanoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(4-Sulfamoylphenyl)Propanoic Acid"],"crossReferences":{"drugbank":["DB08156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4567446","canonicalSmiles":"COc1cc(C(=O)N2CCC3(CC2)CC(=O)c2c(cnn2C(C)C)C3)cc(-c2ccc(C(=O)O)cc2)n1","inchiKey":"LXZMHBHEXAELHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLESACOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clesacostat","PF-05221304","PF05221304","Pf-05221304"],"childChemblIds":["CHEMBL4650217"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594492","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"REVUSIRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-51547","Revusiran"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["Orphanet_271861","Orphanet_85447"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594511","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VUTRISIRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALN-65492","Votrisiran","Vutrisiran"],"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594569","drugType":"Unknown","blackBoxWarning":false,"name":"KY-1005","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amlitelimab","KY-1005","KY-1005-2D10","KY1005","KY1005-2D10","Ky-1005","Ky1005"],"linkedTargets":{"rows":["ENSG00000117586"],"count":1},"linkedDiseases":{"rows":["HP_0000964","EFO_0000274","EFO_0000540"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4649378","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OCc4ccc(F)cc4)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"FVQGMXUKQAXPIP-JLTQGABHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUBENTYLOSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4''-(p-fluorobenzyl)tylosin a","ABBV-4083","ABBV4083","Abbv-4083","Flubentylosin"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650320","canonicalSmiles":"CC(C)C(=O)OC[C@H]1O[C@@H](n2cc/c(=N\\O)[nH]c2=O)[C@H](O)[C@@H]1O","inchiKey":"HTNPEHXGEKVIHG-QCNRFFRDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLNUPIRAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EIDD-2801","Eidd 1931-isopropyl ester","Eidd-2801","MK-4482","Molnupiravir"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650380","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"BELCESIRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belcesiran","DCR-A1AT","DCR-S1459"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650397","drugType":"Unknown","blackBoxWarning":false,"name":"GV-971","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GV-971","Gv-971","HS971","Oligomannurarate(971)"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650411","drugType":"Antibody","blackBoxWarning":false,"name":"OCIPERLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-A1217","Bgb-a1217","Ociperlimab"],"linkedTargets":{"rows":["ENSG00000181847"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005922","MONDO_0002974","EFO_0000182","EFO_0000403","EFO_0000702","EFO_0003060"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4650494","drugType":"Unknown","blackBoxWarning":false,"name":"NLG-802","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NLG-1564","Nlg-802","Nlg802"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL486386","canonicalSmiles":"O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12","inchiKey":"HKEAFJYKMMKDOR-VPRICQMDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUERARIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daidzein 8-c-glucoside","Kakonein","NPI 031G","NSC-380711","Puerarin","Puerarin 80 mm"],"crossReferences":{"PubChem":["85148721"],"Wikipedia":["Puerarin"],"drugbank":["DB12290"],"chEBI":["8633"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL492265","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1","inchiKey":"GQXMJOSCBRZMKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL492265","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494072","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1","inchiKey":"MNEXDVSJIUQQRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL494072","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08351"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508360","canonicalSmiles":"CO[C@@H]1C/C(C)=C\\[C@H]2CC[C@@H]([C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C[C@@H]([C@H](C)C[C@@H]3CC[C@@H](O)[C@H](OC)C3)OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]3(O)O[C@@H](CC[C@H]3C)C1)N(c1ccccc1)O2","inchiKey":"MEHAQNIQDYZFHE-KRWDJPGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILS-920","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ILS 920","Ils-920","WAY-265920"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL538","canonicalSmiles":"Nc1ccccc1","inchiKey":"PAYRUJLWNCNPSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aniline","Phenylamine","benzenaminium"],"crossReferences":{"PubChem":["144207543","17390041"],"Wikipedia":["Aniline"],"drugbank":["DB06728"],"chEBI":["17296"]},"childChemblIds":["CHEMBL3182415","CHEMBL3392014"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550348","canonicalSmiles":"O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1","inchiKey":"BOFQWVMAQOTZIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEFERASIROX","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deferasirox","Exjade","Jadenu","Jadenu sprinkle"],"synonyms":["Deferasirox","ICL-670","ICL-670A","ICL670","ICL670A","Osveral"],"crossReferences":{"DailyMed":["deferasirox"],"PubChem":["144206479","170464723","50126305"],"Wikipedia":["Deferasirox"],"drugbank":["DB01609"],"chEBI":["49005"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for myelodysplastic syndrome and has 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL593430","canonicalSmiles":"C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C","inchiKey":"IUVMAUQEZFTTFB-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAGABALIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atagabalin","PD 0200390","PD-0200,390","PD-0200390","PD0200390"],"crossReferences":{"Wikipedia":["Atagabalin"],"drugbank":["DB12032"]},"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000157445","ENSG00000100346","ENSG00000165995","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000105605","ENSG00000167535","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000108878","ENSG00000006283","ENSG00000130433","ENSG00000141837","ENSG00000075429","ENSG00000182389","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL609583","canonicalSmiles":"O=C(NO)c1cnc(N2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1","inchiKey":"MUTBJZVSRNUIHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-306465","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-16241199","R-306465","R306465"],"crossReferences":{"drugbank":["DB12382"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL609728","canonicalSmiles":"Cc1ccc(NCCCN)c([N+](=O)[O-])c1","inchiKey":"FKZUPMCBVURANR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL609728","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05492"]},"childChemblIds":["CHEMBL3221737"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL635","canonicalSmiles":"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"XOFYZVNMUHMLCC-ZPOLXVRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISONE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortan","Cortancyl","Decortisyl","Delta-dome","Deltasone","Fernisone","Liquid pred","Lodotra","Meticorten","Orasone","Paracort","Prednicen-m","Prednisone","Prednisone intensol","Rayos","Servisone","Sterapred"],"synonyms":["3en3hg4wsw","Decortin","Dehydrocortisone","Metacortandracin","NSC-10023","Prednisone","Prednisone anhydrous","Prednisone tablets","Supercortil"],"crossReferences":{"DailyMed":["prednisone"],"PubChem":["144204565","144208762","144210516","170464847","17389753","50085971","56314869","75351"],"Wikipedia":["Prednisone"],"drugbank":["DB00635"],"chEBI":["8382"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005952","EFO_1001345","HP_0002043","EFO_0006803","EFO_0000096","EFO_0002690","EFO_0000676","EFO_0003063","EFO_1002049","EFO_0008517","HP_0003072","EFO_0009449","EFO_1001946","EFO_0009538","EFO_1001365","MONDO_0044889","EFO_1000049","EFO_0004256","MONDO_0004979","EFO_0001378","EFO_0000341","MONDO_0015564","EFO_0001062","EFO_0009491","Orphanet_84","EFO_1001896","MONDO_0044903","MONDO_0005271","Orphanet_586","EFO_1000684","EFO_1001413","HP_0010450","MONDO_0003541","EFO_0002430","EFO_0005676","EFO_1000694","Orphanet_77260","MONDO_0005180","EFO_0000196","EFO_0004826","EFO_0000183","EFO_1001417","MONDO_0002083","EFO_0008590","EFO_0000403","EFO_0003898","Orphanet_44890","EFO_0003929","EFO_0001358","EFO_0000319","MONDO_0001085","EFO_0003843","Orphanet_238510","EFO_0000764","EFO_1001947","MONDO_0024880","MONDO_0005178","MONDO_0005148","EFO_1001927","MONDO_0000873","EFO_0003777","EFO_0004274","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0009456","EFO_0007520","EFO_1002050","HP_0001871","MONDO_0015540","HP_0003419","MONDO_0003540","Orphanet_98878","EFO_0007541","EFO_1000749","EFO_0004719","EFO_0005856","EFO_1000039","EFO_0007168","MONDO_0044881","EFO_0002429","HP_0001873","EFO_1001119","Orphanet_98896","MP_0001845","EFO_1000986","EFO_0000398","Orphanet_282","MONDO_0000432","MONDO_0019471","EFO_1000764","MONDO_0044887","MONDO_0001280","HP_0001094","EFO_1001435","EFO_1001469","HP_0001915","EFO_1001264","Orphanet_309144","EFO_0003047","EFO_1000158","EFO_0009609","MONDO_0000430","MONDO_0015128","EFO_0003060","EFO_0000621","EFO_1001383","EFO_0007227","MONDO_0005301","EFO_0000095","EFO_0007403","EFO_0005611","EFO_1001467","EFO_0004708","EFO_0011061","EFO_0007486","EFO_0000275","EFO_0000756","MONDO_0018896","HP_0011868","HP_0004798","EFO_1000318","MONDO_0015760","EFO_1001935","MONDO_0008903","EFO_0003884","EFO_0004991","MONDO_0004976","EFO_0000198","MONDO_0013730","EFO_0009012","EFO_0007537","EFO_0000384","MONDO_0008315","EFO_0001663","EFO_0009448","EFO_0007187","EFO_1001231","EFO_0003032","EFO_1000391","EFO_0000574","EFO_0003767","EFO_0003086","EFO_0007405","EFO_1000997","EFO_1001205","EFO_0007498","EFO_0007313","MONDO_0007254","EFO_0000255","MONDO_0004095","MONDO_0017287","EFO_0004289","EFO_0007208","EFO_0005140","EFO_0004238","Orphanet_797","EFO_0000616","EFO_0000765","HP_0002571","MONDO_0000870","EFO_0000222","EFO_0003818","EFO_0004599","EFO_0007257","EFO_0005297","EFO_1000499","EFO_1001194","MONDO_0002367","MONDO_0018906","EFO_0007141","EFO_0000557","EFO_0007167","EFO_0003956","EFO_0000729","EFO_1000131","EFO_0005558","EFO_0008997","EFO_0004251","EFO_0007448","MONDO_0019088","EFO_0000182","EFO_1002030","EFO_0004255","EFO_1001176","MONDO_0003334","EFO_0000094","EFO_0004276","EFO_0005854","EFO_0005761","EFO_1001857","EFO_0000220","EFO_1001466","Orphanet_3389","EFO_0004236","MONDO_0018848","EFO_0004194","MONDO_0017596","EFO_1000784","Orphanet_418","EFO_1001209","MONDO_0100096","Orphanet_90794","MONDO_0044917","EFO_0002428","EFO_1001051","HP_0012424","EFO_0000699","MONDO_0009348","EFO_0005801","EFO_1001222","EFO_0005319","EFO_1000965","EFO_0000318","EFO_0000768","DOID_13406","EFO_0003778","EFO_0000373","EFO_0000209","EFO_0000274","EFO_0002950","EFO_0008518","EFO_0005531","EFO_0004254","EFO_0003144","EFO_0000673","EFO_0002626","EFO_0010580","EFO_1000635","EFO_0000479","EFO_0000685","HP_0001952","Orphanet_65","EFO_1000941","EFO_0002609","EFO_0000311","EFO_0003106","EFO_0000211","MONDO_0004975","EFO_0000691","EFO_0001063","HP_0012410"],"count":243},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 62 approved and 139 investigational indications."}
{"id":"CHEMBL7162","canonicalSmiles":"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1OC1CCCCC1","inchiKey":"KTDZCOWXCWUPEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NS-398","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NS-398"],"crossReferences":{"PubChem":["11113808","26751985"],"drugbank":["DB14060"],"chEBI":["73458"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL85320","canonicalSmiles":"C[C@H](NC(=O)[C@@H](CC(=O)NO)Cc1ccccc1)C(=O)O","inchiKey":"OJCFZTVYDSKXNM-GXSJLCMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KELATORPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kelatorphan"],"crossReferences":{"drugbank":["DB08040"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
